JPRN-UMIN000021105招募中未知
Basic research of immunotherapy using dendritic cells derived from induced pluripotent stem cells in healthy donors and cancer patients - Basic research of immunotherapy using dendritic cells derived from induced pluripotent stem cells in healthy donors and cancer patients
Second Department of Surgery, Wakayama Medical University, School of Medicine0 个研究点目标入组 10 人开始时间: 2016年3月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Active other malignancy, except lesions of "carcinoma in situ" or intramucosal location which are curatively resectable 2)Pregnant or lactating woman 3)Sever mental impairment 4)Active or uncontrolled clinically serious infection, except local infection not influencing general status 5)Judged inappropriate by the investigators
研究者
相似试验
尚未招募
不适用
Dendritic cell-based immunotherapy combined with low-dose cyclophosphamide in patients with malignant pleural mesotheliomamesothelioma10035597NL-OMON32554Erasmus MC, Universitair Medisch Centrum Rotterdam10
已完成
不适用
Dendritic cell-based immunotherapy for ovrian cancer patients.NeoplasmsKCT0000831Asan Medical Center10
已完成
1 期
The feasibility of dendritic cell-based immunotherapy targeting synthesized long peptides containing helper epitopes for malignant tumor.JPRN-UMIN000014435Medical Corporation Isokai Seren Clinic Tokyo10
进行中（未招募）
1 期
Dendritic cell vaccine immunotherapy in paediatric high grade gliomaPaediatric High grade glioma, excluding brain stem gliomasMedDRA version: 16.1 Level: PT Classification code 10065443 Term: Malignant glioma System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2010-018447-34-GBGreat Ormond Street Hospital for Children NHS Trust20
进行中（未招募）
1 期
DC for endometrial cancer patientsmetastatic endometrial cancerEUCTR2018-004467-31-NL8